Sung Lee - 22 Feb 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP & Chief Financial Officer
Signature
/s/Sung Lee
Issuer symbol
VIR
Transactions as of
22 Feb 2024
Net transactions value
$0
Form type
4
Filing time
26 Feb 2024, 19:32:19 UTC
Previous filing
29 Mar 2023
Next filing
28 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +40,000 +60% $0.000000 106,500 22 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +80,000 $0.000000 80,000 22 Feb 2024 Common Stock 80,000 $10.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
F2 25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly installments thereafter.